NSU Ex-Dividend Reminder - 3/27/14

Looking at the universe of stocks we cover at Dividend Channel, on 3/27/14, Nevsun Resources Ltd. (NSU) will trade ex-dividend, for its quarterly dividend of $0.035, payable on 4/15/14. As a percentage of NSU's recent stock price of $3.52, this dividend works out to approximately 0.99%, so look for shares of Nevsun Resources Ltd. to trade 0.99% lower — all else being equal — when NSU shares open for trading on 3/27/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for NSU, showing historical dividends prior to the most recent $0.035 declared by Nevsun Resources Ltd.:

NSU+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from NSU is likely to continue, and whether the current estimated yield of 3.98% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of NSU shares, versus its 200 day moving average:

Nevsun Resources Ltd. 200 Day Moving Average Chart

Looking at the chart above, NSU's low point in its 52 week range is $2.65 per share, with $4.33 as the 52 week high point — that compares with a last trade of $3.50.

According to the ETF Finder at ETF Channel, NSU makes up 1.01% of the Junior Miners ETF ( JUNR) which is trading higher by about 0.8% on the day Tuesday.

In Tuesday trading, Nevsun Resources Ltd. shares are currently up about 2% on the day.

More from Stocks

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Spotify Announces Major Upgrade to Free Mobile App

Spotify Announces Major Upgrade to Free Mobile App

Looks like Coca-Cola's M&A Strategy Is Paying Off

Looks like Coca-Cola's M&A Strategy Is Paying Off

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug